Serous Retinal Detachment Associated with Dome-Shaped Macula and Staphyloma Edge in Myopic Patients before and after Treatment with Spironolactone
Table 1
Patient demographics.
Patient
Age
Sex
Group
Staphyloma type
SRD
Systemic disease
Spherical equivalent
AL (mm)
1
43
M
SE
Inferior
RE
None
RE: −1.25
RE: 25.66
LE: −1.25
LE: 26
2
51
M
SE
Inferior
RE, LE
Porphyria
RE: 0.50
RE: 28.7
LE: −7.75
LE: 27.3
3
49
F
SE
Inferior
None
Arthrosis
RE: −1.25
RE: 25.72
LE: −1.00
LE: 25.67
4
32
F
SE
Inferior
RE, LE
Hypothyroidism
RE: −21.00
RE: 31.65
LE: −17.00
LE: 31.17
5
43
F
SE
Inferior
LE
None
RE: 0.00
RE: 30.10
LE: 0.00
LE: 30.55
6
58
F
SE
Inferior
RE, LE
SLE
RE: −0.50
RE: 25.95
LE: −0.25
LE: 26.42
7
36
F
SE
Inferior
RE
Hypothyroidism
RE: −5.50
RE: 27.26
LE: −17.00
LE: 28.02
8
44
F
SE
Inferior
LE
None
RE: −3.75
RE: 29.06
LE: −4.75
LE: 29.52
9
64
F
SE
Inferonasal
LE
None
RE: −3.75
RE: 30.77
LE: −5.50
LE: 26.07
10
56
M
DSM
None
RE
None
RE: −4.00
RE: 25.43
LE: −5.25
LE: 25.7
11
54
F
DSM
Inferonasal
RE
HBP
RE: −1.00
RE: 25.52
LE: −0.75
LE: 24.93
12
51
F
DSM
Inferonasal
LE
None
RE: −4.00
RE: 29.16
LE: −5.50
LE: 30.11
M, male; F, female; SE, staphyloma edge; DSM, dome-shaped macula; SRD, serous retinal detachment; HBP, high blood pressure; SLE, systemic lupus erythematosus; RE, right eye; LE, left eye; AL: axial length.
